Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Primary Dysautonomias 1Polycystic Ovary Syndrome 1Metabolic Syndrome 1Insulin Resistance 1Hyperandrogenism 1

Interventions

Metformin 7Magnetic Resonance Spectroscopy 2Inositol 2Exercise 2Ethinyl Estradiol 2maltodextrin 1drospirenone and ethinyl estradiol combination 1drospirenone 1Walking 1Triptorelin Pamoate 1Testosterone 1Sugars 1Spironolactone 1Pyruvic Acid 1Preoperative Exercise 1Pioglitazone 1Phlebotomy 1Pancreaticoduodenectomy 1Orchiectomy 1Leuprolide 1Hepatectomy 1Flutamide 1Etanercept 1Estrogens 1Diet, Reducing 1Diet, Mediterranean 1Diet, Fat-Restricted 1Diet Therapy 1Diet 1Diathermy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Metabolic Syndrome × Bloodletting × Clear all
NCT02460445 2022-07-27

Phlebotomy and Polycystic Ovary Syndrome

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

Phase NA Completed
37 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome, Primary Dysautonomias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡